Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riley Bove

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Multiple Sclerosis and Related Disorders|April 23, 2022
Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple SclerosisTamara B Kaplan, Arpita Gopal, Valerie J Block, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine dosesFrederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, et al.
Neurology|December 23, 2024
Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple SclerosisHannah E Silverman, Alan Bostrom, Alyssa N Nylander, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter studyRiley Bove, Liene Elsone, Enrique Alvarez, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Multiple Sclerosis and Related Disorders|September 27, 2021
Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosisFrederik Novak, Anna Christine Nilsson, Christian Nielsen, et al.
Nature Communications|May 20, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Neurology|November 3, 2017
High risk of postpartum relapses in neuromyelitis optica spectrum disorderEric C Klawiter, Riley Bove, Liene Elsone, et al.
JMIR Human Factors|January 11, 2024
A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrackValerie J Block, Kanishka Koshal, Jaeleene Wijangco, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Multiple Sclerosis and Related Disorders|April 23, 2022
Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple SclerosisTamara B Kaplan, Arpita Gopal, Valerie J Block, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2023
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine dosesFrederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, et al.
Neurology|December 23, 2024
Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple SclerosisHannah E Silverman, Alan Bostrom, Alyssa N Nylander, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter studyRiley Bove, Liene Elsone, Enrique Alvarez, et al.
Multiple Sclerosis and Related Disorders|April 9, 2022
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trialRiley Bove, Annika Anderson, William Rowles, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Multiple Sclerosis and Related Disorders|September 27, 2021
Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosisFrederik Novak, Anna Christine Nilsson, Christian Nielsen, et al.
Nature Communications|May 20, 2024
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosisTanuja Chitnis, Ferhan Qureshi, Victor M Gehman, et al.
Neurology|November 3, 2017
High risk of postpartum relapses in neuromyelitis optica spectrum disorderEric C Klawiter, Riley Bove, Liene Elsone, et al.
JMIR Human Factors|January 11, 2024
A Closed-Loop Falls Monitoring and Prevention App for Multiple Sclerosis Clinical Practice: Human-Centered Design of the Multiple Sclerosis Falls InsightTrackValerie J Block, Kanishka Koshal, Jaeleene Wijangco, et al.
Pageof 18